3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Liver Metastases
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Lobular
1
Breast Neoplasms
1
Interventions
Oxaliplatin
9
Capecitabine
9
pembrolizumab
7
Paclitaxel
7
Fluorouracil
7
Leucovorin
6
Cisplatin
6
zolbetuximab
5
Gemcitabine
4
trastuzumab deruxtecan
3
enzalutamide
3
durvalumab
3
cemiplimab
3
Trastuzumab
3
Pemetrexed
3
Docetaxel
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
darolutamide
2
Taxes
2
Ramucirumab
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Nivolumab
2
Irinotecan
2
Cyclophosphamide
2
Androgen Antagonists
2
Albumin-Bound Paclitaxel
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Positron Emission Tomography Computed Tomography
×
90 days
×
Clear all
No trials found.